http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-9904042-A2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-044 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-60 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-60 |
| filingDate | 1997-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a04b0938cec1645c43eacd4e5a1e658 |
| publicationDate | 2000-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-9904042-A2 |
| titleOfInvention | A method for assessing the risk of cardiovascular disease and other disorders, and phytosterol-based preparations for the treatment of cardiovascular disease and other disorders. |
| abstract | The present invention relates to a method for determining the ratio of serum campester / beta-sieve in an animal, characterized in that the ratio of heat to acampester / beta-sieve is considered an indicator and the ratio to the probability of developing cardiovascular and related diseases. The present invention relates to a method for estimating the risk of cardiovascular disease and alipid disorders in an animal, to a method for increasing the antiproliferative effect of affinity inhibitors on intestinal epithelial cells, and for reducing antihypertensive effects of compositions. The treatment according to the invention can be used in the field of the treatment and risk assessment of diseases associated with stone cholesterol thermostasis. ŕ |
| priorityDate | 1996-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 163.